SYNERGY™
Bioabsorbable Polymer Stent
Designed to heal, the SYNERGY BP Stent has excellent clinical results. In 9 studies of more than 18,000 patients, SYNERGY BP Stent has shown outstanding safety with consistently low ST rates.
Promus PREMIER™ Permanent Polymer Stent
Promus PREMIER features the first customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination, and an enhanced catheter to provide PREMIER outcomes.
Agent™ Drug Coated Eluting Balloon
The AGENT™ Drug Coated Balloon catheter, built on the Emerge™ PTCA Balloon Catheter for exceptional deliverability, and its innovative TransPax™ coating technology, provides a targeted, therapeutic dose of proven, anti-proliferative Paclitaxel to the lesion. It is indicated to treat in-stent restenosis (ISR) and de novo / small vessel disease.*
EXPLORE THE BOSTON SCIENTIFIC
INTERVENTIONAL CARDIOLOGY PORTFOLIO
Join the Complex PCI Community
Join the Complex PCI Community to receive emails ...
and drug delivery systems. More than 3,000 HCPs in Europe have already confirmed.
and drug delivery systems. More than 3,000 HCPs in Europe have already confirmed.
REQUEST A REP
Want to keep the conversation going? Tell us a bit about yourself, and one of our representatives will reach out.